scholarly journals Label-free isolation of circulating tumor cells in microfluidic devices: Current research and perspectives

2013 ◽  
Vol 7 (1) ◽  
pp. 011810 ◽  
Author(s):  
Igor Cima ◽  
Chay Wen Yee ◽  
Florina S. Iliescu ◽  
Wai Min Phyo ◽  
Kiat Hon Lim ◽  
...  
2016 ◽  
Vol 27 ◽  
pp. ix15-ix16
Author(s):  
Y.F. Lee ◽  
N. Ramalingam ◽  
L. Szpankowski ◽  
A. Leyrat ◽  
N.D. Angeles ◽  
...  

2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Manjima Dhar ◽  
Edward Pao ◽  
Corinne Renier ◽  
Derek E. Go ◽  
James Che ◽  
...  

2018 ◽  
Vol 30 (13) ◽  
pp. 4372-4382 ◽  
Author(s):  
Liwei Yang ◽  
He Sun ◽  
Wenning Jiang ◽  
Ting Xu ◽  
Bing Song ◽  
...  

View ◽  
2020 ◽  
Vol 1 (3) ◽  
pp. 20200034 ◽  
Author(s):  
Lisa Miccio ◽  
Flora Cimmino ◽  
Ivana Kurelac ◽  
Massimiliano M. Villone ◽  
Vittorio Bianco ◽  
...  

Micromachines ◽  
2020 ◽  
Vol 11 (8) ◽  
pp. 774 ◽  
Author(s):  
Jie Cheng ◽  
Yang Liu ◽  
Yang Zhao ◽  
Lina Zhang ◽  
Lingqian Zhang ◽  
...  

Circulating tumor cells (CTCs), a type of cancer cell that spreads from primary tumors into human peripheral blood and are considered as a new biomarker of cancer liquid biopsy. It provides the direction for understanding the biology of cancer metastasis and progression. Isolation and analysis of CTCs offer the possibility for early cancer detection and dynamic prognosis monitoring. The extremely low quantity and high heterogeneity of CTCs are the major challenges for the application of CTCs in liquid biopsy. There have been significant research endeavors to develop efficient and reliable approaches to CTC isolation and analysis in the past few decades. With the advancement of microfabrication and nanomaterials, a variety of approaches have now emerged for CTC isolation and analysis on microfluidic platforms combined with nanotechnology. These new approaches show advantages in terms of cell capture efficiency, purity, detection sensitivity and specificity. This review focuses on recent progress in the field of nanotechnology-assisted microfluidics for CTC isolation and detection. Firstly, CTC isolation approaches using nanomaterial-based microfluidic devices are summarized and discussed. The different strategies for CTC release from the devices are specifically outlined. In addition, existing nanotechnology-assisted methods for CTC downstream analysis are summarized. Some perspectives are discussed on the challenges of current methods for CTC studies and promising research directions.


Cancers ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 1005 ◽  
Author(s):  
Giulia Brisotto ◽  
Eva Biscontin ◽  
Elisabetta Rossi ◽  
Michela Bulfoni ◽  
Aigars Piruska ◽  
...  

Circulating tumor cells (CTCs) belong to a heterogeneous pool of rare cells, and a unequivocal phenotypic definition of CTC is lacking. Here, we present a definition of metabolically-altered CTC (MBA-CTCs) as CD45-negative cells with an increased extracellular acidification rate, detected with a single-cell droplet microfluidic technique. We tested the prognostic value of MBA-CTCs in 31 metastatic breast cancer patients before starting a new systemic therapy (T0) and 3–4 weeks after (T1), comparing results with a parallel FDA-approved CellSearch (CS) approach. An increased level of MBA-CTCs was associated with: i) a shorter median PFS pre-therapy (123 days vs. 306; p < 0.0001) and during therapy (139 vs. 266 days; p = 0.0009); ii) a worse OS pre-therapy (p = 0.0003, 82% survival vs. 20%) and during therapy (p = 0.0301, 67% survival vs. 38%); iii) good agreement with therapy response (kappa = 0.685). The trend of MBA-CTCs over time (combining data at T0 and T1) added information with respect to separate evaluation of T0 and T1. The combined results of the two assays (MBA and CS) increased stratification accuracy, while correlation between MBA and CS was not significant, suggesting that the two assays are detecting different CTC subsets. In conclusion, this study suggests that MBA allows detection of both EpCAM-negative and EpCAM-positive, viable and label-free CTCs, which provide clinical information apparently equivalent and complementary to CS. A further validation of proposed method and cut-offs is needed in a larger, separate study.


Lab on a Chip ◽  
2017 ◽  
Vol 17 (19) ◽  
pp. 3291-3299 ◽  
Author(s):  
Wentao Shi ◽  
Shunqiang Wang ◽  
Ahmad Maarouf ◽  
Christopher G. Uhl ◽  
Ran He ◽  
...  

Wavy-herringbone structured microfluidic devices promote capture and collection of rare tumor cells assisted by magnetic particles.


Lab on a Chip ◽  
2014 ◽  
Vol 14 (1) ◽  
pp. 128-137 ◽  
Author(s):  
Majid Ebrahimi Warkiani ◽  
Guofeng Guan ◽  
Khoo Bee Luan ◽  
Wong Cheng Lee ◽  
Ali Asgar S. Bhagat ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document